Cargando…
Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment
Although progress has been indeed made by nanomedicines, their efficacies for cancer treatment remain low, consequently leading to failures in translation to clinic. To improve the drug delivery efficiency, nanoparticles need to change size so as to fully utilize the enhanced permeability and retent...
Autores principales: | Liu, Rui, Hu, Chuan, Yang, Yuanyuan, Zhang, Jingqing, Gao, Huile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438824/ https://www.ncbi.nlm.nih.gov/pubmed/30976492 http://dx.doi.org/10.1016/j.apsb.2018.09.001 |
Ejemplares similares
-
Near-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapy
por: Wu, Bo, et al.
Publicado: (2017) -
Photothermally responsive theranostic nanocomposites for near‐infrared light triggered drug release and enhanced synergism of photothermo‐chemotherapy for gastric cancer
por: Zhou, Taicheng, et al.
Publicado: (2022) -
Theranostic Agent Combining Fullerene Nanocrystals and Gold Nanoparticles for Photoacoustic Imaging and Photothermal Therapy
por: Kawasaki, Riku, et al.
Publicado: (2022) -
Low-dose X-ray enhanced tumor accumulation of theranostic nanoparticles for high-performance bimodal imaging-guided photothermal therapy
por: Wei, Qiaolin, et al.
Publicado: (2021) -
Ultrasmall PtMn nanoparticles as sensitive manganese release modulator for specificity cancer theranostics
por: Guan, Guoqiang, et al.
Publicado: (2023)